Dynamark Life Sciences Private Limited
About Dynamark Life Sciences Private Limited
Data last updated:
Dynamark Life Sciences Private Limited is a private limited company based in Davanagere, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24248KA2016PTC086024.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors Rattehalli Maharudrappa Renuka Prasad and Ganesh Chikkaiah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Davanagere, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.76 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹13.64 Lakh (net margin 2.9%) and EBITDA of ₹13.75 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 35% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dynamark Life Sciences Private Limited's registered office is in Davanagere, Karnataka.
- Registered Address#416/B – 56 Near Ss Hi – Tech Hospital Road, Lakshmi Layout A Block, Davanagere, Karnataka, India – 577007
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dynamark Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dynamark Life Sciences Private Limited, buy the company report.
Financials of Dynamark Life Sciences Private Limited
FY 2025 filings availableDynamark Life Sciences Private Limited reported revenue of ₹4.76 Cr (up 34% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 34% growth in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dynamark Life Sciences Private Limited, buy the company report.
Board of directors of Dynamark Life Sciences Private Limited
Dynamark Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rattehalli Maharudrappa Renuka Prasad | Director | 11 Feb 2016 | 10 Years 9 Months | Current |
| Ganesh Chikkaiah | Director | 11 Feb 2016 | 10 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2024 | 101032247 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dynamark Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dynamark Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dynamark Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dynamark Life Sciences Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Rajashekar Veerabadrappa Gowda ceased to be Director on 31 Dec 2020.
Frequently asked questions
Dynamark Life Sciences is an active private limited company based in Davanagere, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 February 2016 (10+ years old) and is registered under CIN U24248KA2016PTC086024.
Dynamark Life Sciences has 2 current directors:
- Rattehalli Maharudrappa Renuka Prasad - Director
- Ganesh Chikkaiah - Director
The latest financial statements of Dynamark Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Dynamark Life Sciences is U24248KA2016PTC086024. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dynamark Life Sciences was incorporated on 11 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Rajashekar Veerabadrappa Gowda ceased to be Director on 31 Dec 2020. Ganesh Chikkaiah was appointed as Director on 11 Feb 2016. Rattehalli Maharudrappa Renuka Prasad was appointed as Director on 11 Feb 2016.
The registered office of Dynamark Life Sciences is at #416B – 56 Near Ss Hi – Tech Hospital Road, Lakshmi Layout A Block, Davanagere, Karnataka, India – 577007.
Dynamark Life Sciences operates in the chemicals industry, in the manufacturing segment.
Dynamark Life Sciences has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Dynamark Life Sciences is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
